Literature DB >> 15325942

Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.

Dwayne S G Conway1, Peter Buggins, Elizabeth Hughes, Gregory Y H Lip.   

Abstract

The aim of the present study was to investigate whether success or failure of direct-current cardioversion in patients with persistent atrial fibrillation may be related to indexes of inflammation (as indicated by C-reactive protein and interleukin-6, platelet activation [soluble P-selectin levels], endothelial damage/dysfunction [von Willebrand factor], coagulation cascade [tissue factor and fibrinogen], and rheology [plasma viscosity and hematocrit]). We found that C-reactive protein levels are a predictor of initial cardioversion success, although they failed to predict long-term outcome. Although inflammation may be associated with "permanence" of atrial fibrillation, indexes of platelet activation, endothelial damage/dysfunction, or coagulation showed no relation to the immediate and long-term (2-month) cardioversion outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325942     DOI: 10.1016/j.amjcard.2004.04.070

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis.

Authors:  Sanjay Jaiswal; Xian-Bao Liu; Qu-Cheng Wei; Ying-Hao Sun; Li-Han Wang; Liu-Guang Song; Dan-Dan Yang; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

3.  Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?

Authors:  Dhanunjaya R Lakkireddy; George E Blake; Dimpi Patel; Martin Rotter; Atul Verma; Kay Ryschon; Mohammed Khan; Robert Schweikert; Michel Haissaguerre; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2008-05-16

4.  Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.

Authors:  M S O'Neill; A Veves; J A Sarnat; A Zanobetti; D R Gold; P A Economides; E S Horton; J Schwartz
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

5.  Atrial fibrillation and inflammation.

Authors:  Mehmet Ozaydin
Journal:  World J Cardiol       Date:  2010-08-26

6.  Long noncoding RNAs and novel inflammatory genes determined by RNA sequencing in human lymphocytes are up-regulated in permanent atrial fibrillation.

Authors:  Xue-Jing Yu; Li-Hui Zou; Jun-Hua Jin; Fei Xiao; Li Li; Nan Liu; Jie-Fu Yang; Tong Zou
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 7.  Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Authors:  Hadi Ar Hadi; Wael Al Mahmeed; Jassim Al Suwaidi; Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

8.  Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion.

Authors:  Sook Kyoung Kim; Hui-Nam Pak; Jae Hyung Park; Kyoung Jeong Ko; Jihei Sara Lee; Jin Wi; Jong Il Choi; Young-Hoon Kim
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

9.  Assessment of atrial conduction time in patients with polycystic ovary syndrome.

Authors:  Regayip Zehir; Can Yucel Karabay; Gonenc Kocabay; Arzu Kalayci; Ozge Kaymaz; Ahmet Cagrı Aykan; Emre Karabay; Cevat Kirma
Journal:  J Interv Card Electrophysiol       Date:  2014-07-09       Impact factor: 1.900

Review 10.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.